The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News

Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...

Three UK drugs firms investigated over alleged Iraq bribes
THREE British pharmaceutical companies are under investigation by the Serious Fraud Office over alleged bribes paid to the former Iraqi...

Drug firms face grilling on 'Saddam bribes'
Executives from GlaxoSmithKline, AstraZeneca and Eli Lilly may be interviewed by Britain's Serious Fraud Office as part of its investigation into...

British Pharma Biggies Face Iraq Probe
Britain's largest pharmaceutical companies are facing questions about the controversial UN oil for food program in Iraq...

UK Probes Glaxo, AstraZeneca Over Iraqi Bribe Allegations
Drug makers GlaxoSmithKline PLC and AstraZeneca PLC have been asked to give documents to the United Kingdom's Serious Fraud...

UK drug firms told to hand over files in Iraq investigation
The Serious Fraud Office has ordered the British drug companies GlaxoSmithKline and AstraZeneca to hand over confidential emails and files relating to...

Lilly joins SFO 'bribes' list
American group Eli Lilly has become the third drug company to confirm a request from Britain's Serious Fraud Office to...

Probe into Iraqi drug contracts stepped up
GlaxoSmithKline and AstraZeneca, the pharmaceutical groups, have been ordered to release confidential documents to the Serious Fraud...

UK fraud regulator investigates 3 drug companies over bribes to Saddam
Britain's Serious Fraud Office has demanded documents from three major drug makers in connection with allegations that the companies paid bribes...

3rd British pharmaceutical company under suspicion of fraud
Eli Lilly has been asked to hand over documents as part of an investigation into alleged bribes paid to former Iraqi dictator Saddam Hussein...

Glaxo, AstraZeneca Get UK Document Request on Oil for Food
GlaxoSmithKline Plc, the world's second-largest drugmaker, and AstraZeneca Plc, the UK's No.2 pharmaceutical company...

Drug firms probed over Iraq cash
GlaxoSmithKline and AstraZeneca have been asked to hand over papers as part of a probe into bribes allegedly paid to Saddam Hussein's former Iraq regime...

UK fraud office demands drug firms' Iraq documents
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) and AstraZeneca Plc (AZN.L: Quote, Profile, Research) said on Sunday Britain's...

UK fraud watchdog demands documents from GlaxoSmithKline and...
Britain's Serious Fraud Office has demanded documents from drug giants GlaxoSmithKline PLC and AstraZeneca PLC in connection with allegations...

Drug firms face Iraq bribes probe
Pharmaceutical companies GlaxoSmithKline and AstraZeneca have been asked to hand over documents to the Serious Fraud Office as part of its investigation...

SFO targets drug groups over UN scandal
Executives from GlaxoSmithKline (GSK), AstraZeneca and Eli Lilly could be interviewed by the Serious Fraud Office (SFO) as part of its investigation into...

Most Popular Now

Sustained cellular immune dysregulation in individ…

COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or have mild symptoms. Others, espe...

New virtual screening strategy identifies existing…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, c...

Pfizer and BioNTech to supply the U.S. with 100 mi…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the compan...

European Commission authorizes COVID-19 vaccine Mo…

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the European Commission has granted a cond...

An in vitro study shows Pfizer-BioNTech COVID-19 v…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB...

Serum Institute of India obtains emergency use aut…

AstraZeneca's COVID-19 vaccine has been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco for the act...

CureVac and Bayer join forces on COVID-19 vaccine …

Bayer has signed a collaboration and services agreement with CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines b...

New findings help explain how COVID-19 overpowers …

Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondri...

China grants conditional market approval for Sinop…

The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of China, C...

Novavax announces initiation of PREVENT-19 pivotal…

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced initiation of PREVEN...

AstraZeneca's COVID-19 vaccine authorised for emer…

AstraZeneca's COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being released today so that vaccinations may begin early in the New...

Pfizer and BioNTech to supply the European Union w…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will supply an additional 100 million doses of COMIRNATY®, the companies' COVID-19 Vaccine, to the 2...